American Uranium Issues 11.88 Million Unquoted Options Expiring 30 June 2029

Sonal Goyal

09 November 2026 04:47 PM AEDT

American Uranium Issues 11.88 Million Unquoted Options Expiring 30 June 2029

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

American Uranium Ltd (ASX:AMU) has issued 11,880,000 unquoted options expiring 30 June 2029 with an exercise price of $0.16, according to an Appendix 3G filing lodged with the exchange on 9 November 2026.

Key Points

11,880,000 unquoted options (ASX code: AMUAR) expiring 30 June 2029 at an exercise price of $0.16 were issued on 9 November 2026
6,940,000 of the options were issued for cash consideration at AUD $0.00001 per option
4,940,000 options were issued as attaching options to Tranche 1 Convertible Note holders, as approved by shareholders on 23 October 2026
Following the issue, total AMUAR options on issue stand at 32,298,192
A further 19,000,000 fully paid ordinary shares are yet to be issued to complete the previously announced transaction

Option Issue Details and Consideration

The 11,880,000 options issued on 9 November 2026 are unquoted and are not intended to be quoted on the ASX. The issue comprises two tranches. The first tranche of 6,940,000 options was issued for cash consideration at AUD $0.00001 per option, denominated in Australian dollars. The second tranche of 4,940,000 options was issued as attaching options to Tranche 1 Convertible Note holders, with no cash consideration received for this portion. The filing states the second tranche was approved by shareholders on 23 October 2026.

Link to Previously Announced Transaction

According to the filing, the options were issued as part of a transaction previously announced to the market via an Appendix 3B lodged on 25 August 2026, titled "New - Proposed issue of securities - AMU," and classified as a placement or other type of issue. The filing confirms that further securities remain to be issued to complete the transaction, specifically 19,000,000 fully paid ordinary shares, which had not yet been issued at the time of the 9 November 2026 notification.

American Uranium Securities on Issue Following the Transaction

Following the issuance of the options, American Uranium's total quoted securities on ASX comprise 130,268,297 fully paid ordinary shares (ASX: AMU) and 47,760,385 options expiring 25 September 2028 (ASX: AMUOC). Unquoted securities on issue include 32,298,192 AMUAR options expiring 30 June 2029 at $0.16, 1,235,000 convertible notes (AMUAS), 825,000 Class D Performance Rights expiring 11 October 2027 (AMUAN), and 50,000 Class C Performance Rights expiring 23 February 2027 (AMUAI).

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.